Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 8150538)

Published in Int J Cancer on April 01, 1994

Authors

L E Hansson1, J Baron, O Nyrén, R Bergström, A Wolk, A Lindgren, H O Adami

Author Affiliations

1: Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden.

Articles citing this

Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Community Health (2000) 3.23

Relation between number of siblings and adult mortality and stroke risk: 25 year follow up of men in the Collaborative study. J Epidemiol Community Health (2003) 2.25

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73

Early gastric cancer shows different associations with adipose tissue volume depending on histological type. Gastric Cancer (2008) 1.42

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer (2001) 1.26

Early-life family structure and microbially induced cancer risk. PLoS Med (2007) 1.06

Fish sauce and gastric cancer:an ecological study in Fujian Province,China. World J Gastroenterol (2000) 1.04

Height, weight, and body mass index associations with gastric cancer subsites. Gastric Cancer (2013) 0.98

Socioeconomic status and stomach cancer incidence in men: results from The Netherlands Cohort Study. J Epidemiol Community Health (1998) 0.87

Number of siblings and the risk of solid tumours: a nation-wide study. Br J Cancer (2007) 0.84

Association between Helicobacter pylori infection and adult height. Eur J Epidemiol (2005) 0.81

Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? EPMA J (2010) 0.80

Parental family structure, Helicobacter pylori, and gastric adenocarcinoma. PLoS Med (2007) 0.75

Prospective comparison of the perceived preoperative computed tomographic, endosonographic and histopathological stage of oesophageal cancer related to body mass indices. Eur Radiol (2008) 0.75

Articles by these authors

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (1993) 9.88

Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81

Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65

Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59

High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31

Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25

The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21

Cost-effectiveness analysis in a setting of budget constraints--is it equitable? N Engl J Med (1996) 4.13

Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08

Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05

Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86

Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80

Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79

The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77

Stressful life events and Graves' disease. Lancet (1991) 3.63

Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42

Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37

Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34

Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31

Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28

Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17

Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13

A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13

Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10

Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr (1999) 3.03

Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia (2006) 2.91

Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88

Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81

Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78

Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69

Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65

Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64

10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64

Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61

The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57

Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia (2007) 2.54

International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52

Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52

The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51

Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51

Test-retest variability in glaucomatous visual fields. Am J Ophthalmol (1989) 2.40

Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39

Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology (2001) 2.34

Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32

Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31

Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30

Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30

Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29

Fatty fish consumption and risk of prostate cancer. Lancet (2001) 2.27

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer (2007) 2.23

Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16

Effect of type of alcoholic beverage in causing acute pancreatitis. Br J Surg (2011) 2.12

Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12

Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09

Venous thromboembolism and cancer. Lancet (1998) 2.08

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07